Mr Andrew D PriceAndrew D. Price

ADP EyeCare
 

Contact: patients@adp-eyecare.co.uk

 

Mrs Vanessa Uden Vanessa Uden

Dispensing Optician and Contact Lens Optician

Contact: vanessa@strictlylocum.co.uk

Mrs Elizabeth RalphMrs Elizabeth Ralph

Professional Services Consultant
Contact Lens Specialist

Contact: beth.ralph19@icloud.com

 

Mr Ganeshbabu MahalingamMr Ganeshbabu Mahalingam

Optometrist and Contact Lens Specialist

Contact: patientcare@apexeyeandvisioncare.co.uk

Top Panel

Andrew D Price FBDO(Hons)CL, COA

Who I am, what I do and how I can help you!

Read More

Teaching with model eye

I provide lectures and workshops, teaching colleagues and students

Read More

Dry/Watery Eye – how I can help

The eyes surface and tears are complex – trial and error is not the way!

Read More

Lid conditions need microscopic examination

It is not possible to diagnose and successful treat without a specialist exam

Read More

Cause of Contact Lens Discomfort

Specialist exam techniques can show how contact lens wear can be successful

Read More

Dry/Watery Eye – how I can help ?

The eyes surface and tears are complex – trial and error is not the way!

Cause of Contact Lens Discomfort

Specialist exam techniques can show how contact lens wear can be successful

Lid conditions need microscopic examination

It is not possible to diagnose and successful treat without a specialist exam

Short-sighted eyes grow longer!

Is your child suitable for Myopia (Progression) Management?

Colour vision enhancement

Specialist contact lenses may give improved colour vision discrimination

Ortho-K - clear vision without the need for surgery, glasses or contact lenses

Latest technology for diagnosis

Specialist technology can now identify reasons for dry eye/contact lens discomfort

Latest technology for treatment

Specialist technology can now treat dry eye/contact lens discomfort

Dry Eye Clinic Video

Why a clinic appointment is so important

Latest News

LATEST NEWS! This column will carry the latest news for ADP-EyeCare patients and/or prospective patients. 

01/04/2021: Mr Ganeshbabu Mahalingam's CL Referral Form can be found here

27/03/2021: Mr Ganeshbabu Mahalingam MPhil PhD FCOptom FBCLA ProfHigherGlaucoma publishes his Portfolio and advises his CL clinics start early April. 

15/03/2021: Beth Ralph updates Dry Eye and Contact Lens Referral Forms with latest email address. 

03/03/2021: State of the Art Eye Mapping and Tear Fim Analysis video added to site under 'Also Interesting'

15/02/2021: How the Human Eye Works video added to site under 'Also Interesting'

23/01/2021: Ortho-K article and video on being spectacle and contact lens free during the day published here

19/01/2021: Vanessa Uden is now welcoming referrals and self-referrals to her shortly commencing contact lens clinics in West Byfleet, Camberley and Godalming. See her 'Portfolio' under the 'ADP-EyeCare' sub-menu amd her optional 'CL Referral Form' under 'Contact Lens Clinic'

12/01/2021: Further questions added to both Contact Lens and Dry Eye FAQs. Find under Dry Eye and Contact Lens Clinic menu headings. 

21/12/2020: Beth Ralph, Vanessa Uden and Andrew Price wish everyone a merry and safe Christmas and a happy New Year! ADP EyeCare is available for non-urgent patient communication by email, phone or Webcam every day of the year (phone or webcam by prior arrangement). If, having looked around this website, you think we can help you in relation to dry eye and/or contact lens wear email patients@adp-eyecare.co.uk

08/12/2020: Read Hand Hygiene - a Science Behind it!

07/12/2020: The ADP Consultancy/ADP-Eye-Care hope to have trials under way in 2021 looking at an in-practice treatment and/or home therapy for contact lens discomfort and/or dry eye. For further information go to Clinical trials - Can You Help?

01/12/2020: In-practice treatments for dry eye/blepharitis are outlined here.

 

 

 

A+ R A-

Clinical Trials - Can You Help?

Clinical trials - recruiting subjects

The ADP Consultancy conducts clinical trials for the purpose of increasing our knowledge in the field of eye care.  We hope to have trials under way in 2021 looking at an in-practice treatment for contact lens discomfort and/or at home therapy for dry eye, if you think you would like to find out more about how you might help, or may be interested in future trials and live within traveling distance of Nantwich, Southport, Leyland, Sheffield, Chestefield, Wakefield or in the Berks/Hants/Surrey region please email This email address is being protected from spambots. You need JavaScript enabled to view it.  We are happy to receive communication from other ECPs/HCPs on referrals for the trials and returning patients to you for continuing care with reports on each patient. 

Nuvision Logo

DOORS Press Release

download Dry Eye Study Flyer

A new health study is to be launched in a bid to help millions who suffer from ‘dry eye’.
One in four of us will suffer from the debilitating condition with symptoms ranging from sore eyes through to short-term blurred vision.
Now experts based in Birmingham and Nottingham are looking for people to take part in the study, wearing a special contact lens for under 2 weeks, which could lead to longer term relief.
Volunteers are being sought for the research which is being conducted by Aston University’s Eye Clinic in collaboration with Nottingham’s NuVision Biotherapies, a company formed with backing of the University of Nottingham.
The study follows the development of an eyesight-saving product, Omnigen, derived from human amniotic membrane donated from caesarean sections. Up until recently it could only be applied surgically but NuVision have created OmniLenz.
This bespoke contact lens allows the surgery-free application of Omnigen. Such a simple, 5-minute procedure enables eyecare professions to treat ocular surface diseases, as simply as applying a contact lens, early and more effectively without the need for surgery.
Professor James Wolffsohn, principle investigator of the study, said: “Dry eye can be a severe, chronic and debilitating disease. Amniotic membrane has shown great promise in its management, but retention on the eye is required. We want to see how we can help people with dry eye by applying this lens.
“Omnigen is already successfully used throughout the NHS and the study aims to demonstrate that the wound healing benefits of Omnigen are easily transferable to those suffering and living with dry eye disease.”
This trial is designed as a prospective, double-arm, investigational randomised study to examine the change in dry eye disease symptoms and pathology following the in-clinic OmniLenz transplantation of Omnigen for patients suffering from moderate to severe dry eye disease.
Founder and Chief Scientific Officer of NuVision, Dr. Andrew Hopkinson, said: “Amniotic membrane has clinically proven wound healing capability which historically has been reserved for severe surgical situations. Through the innovation of OmniLenz application of Omnigen in an out-patient setting, NuVision is already helping to treat patients with severe ocular surface injuries. However, this clinical trial now aims to demonstrate a benefit to those suffering from dry eye disease.”
NuVision received support from the INSTILS project – part-funded through the European Regional Development Fund (ERDF) and delivered by Medilink East Midlands. Thanks to INSTILS support, NuVision received an Innovation Support Grant, to the value of £12,920, which will allow them to undertake this study with Aston University, accelerating the clinical trial process and bringing NuVision’s novel approach to market faster than would have otherwise been possible.
Darren Clark, Chief Executive of Medilink East Midlands, said: “NuVision has a truly innovative and outstanding approach to treating dry eye disease. I am confident that the help we’ve given to them, both in terms of the Innovation Support Grant and the dedicated time and effort that one of our Innovation Advisers has invested in them, will make their treatment available quicker, improving outcomes for patients worldwide.”
If you are interested in taking part in the study, please contact This email address is being protected from spambots. You need JavaScript enabled to view it. or call +44 (0) 121 204 4400 to arrange a consultation.

Contact Lens Discomfort Trial - In-Practice Treatment

We are looking for subjects who find their contact lenses are not as comfortable as they would like, especially at the end of the day. The trial does not involve changing lenses or solutions but rather treating the eye's vital meibomian glands that secrete protective oils into the tears. The object of the clinical trial is to determine if, and for how long, a one-off in-practice treatment reduces contact lens discomfort. If you would like to know more about this trial please and could attend the clinics in Nantwich, Southport or Leyland please email This email address is being protected from spambots. You need JavaScript enabled to view it. 

Made-to-Order Multifocal Contact Lens Trial

Would a 'tailor made' made-to-order multifocal lens perfor better than the equivalant widely prescribed off-the-shelf alternative? A few statistically signifianct differences were found for visual acuity and subjective vision and the overall performance of 'tailor made' lens was much better than off-the-shelf alternative. These aspects could be leveraged in a marketing campaign among contact lens practices seeking to have better overall success with multifocal soft conact lenses. 08/01/2017 Update: This trial has now completed and closed with report issued to sponsor. 

Multi-Focal Contact Lens Trial (two separate trials)

We are looking for subjects who are over 42 and require different prescriptions for distance and near, bifocal/varifocal glasses, two pairs of glasses, removes distance glasses to read, glasses over contact lenses to read or monovision contact lenses. The object of the clinical trial is to determine if vision with contact lenses changes over a time period. Subjects who complete the clinical trial and are successful with the sponsor's lenses will be offered 3 months lenses free-of-charge (approx value £150.00). The subjects would be prescribed one or two pairs of lenses to wear for a week, normally three to four practice visits will be required. 05/05/2017 Update: Both of these trials has now completed and closed with report issued to sponsor.  

Contact Lens Discomfort Trial

We are looking for subjects who find their contact lenses are not as comfortable as they would like, especially at the end of the day. The trial does not involve changing lenses or solutions but rather using a means to retain more tears on the eye surface. the object of the clinical trial is to determine if retaining more tears on the eye surface reduces contact lens discomfort. Subjects who complete the clinical trial will be given £100.00 practice credit. 23/12/2016 Update: This trial has now completed and closed. Interim results have been published. If you are interested in the interim results and what it may mean to you as a Contact Lens wearer email This email address is being protected from spambots. You need JavaScript enabled to view it. 24/03/2017 Update: This trial has now completed and closed with report issued to sponsor. A clinical trials poster was presented at the BCLA CC in 2017.

Contact Lens Uncorrected Cyl Trial

We are looking for subjects (both CL and non-CL wearers) between 18 and 40 who have cylinder corrections up to and including -1.00 at any axis with sphere powers obtainable in daily disposable lenses. The subjects will wear both a toric and a spherical lens on two different occasions with the aim of determining if their is a objective and/or subjective visual benefit to correcting small cyls with toric lenses. Subjects who complete the trial will be offered £50 payment and £50 practice credit. For further information email This email address is being protected from spambots. You need JavaScript enabled to view it. 06/03/2018 UpdateThis trial has now completed and closed with report issued to sponsor. A clinical trials poster was presented at Optrafair in 2018. 

Use of this website indicates the user has read, understands and accepted all the terms of use as outlined in the Disclaimer.